24/7 Market News

Lunchtime Venture Snack, by 24/7 Market News

2018-07-30T13:48:33+00:00 Jul. 30, 2018 12:52PM EST|

Lunchtime Venture Snack for July 30, 2018

Drone UDA, Inc, (OTCQB: DRUS) is a venture exchange that’s trading about 16.6% higher today, while closing in on 50 million shares traded.

RECENT NEWS: DRUS announced, on July 24th, that the Commonwealth of Kentucky awarded Drone USA a one-year master agreement to supply drones, unmanned aircraft systems and accessories to Kentucky state agencies. The contract may be extended at the completion of the initial contract period for four additional one-year periods.

CV Sciences Inc. (OTCQB: CVSI) traded on the venture exchange rallied up around 9% to $2.95 on over $5million trading volume and closing in on 1800 trades so far this session.

RECENT NEWS: CVSI, which bills itself as the preeminent supplier and manufacturer of hemp-based phytocannabinoids including cannabidiol (CBD) oil and developer of specialty pharmaceutical therapeutics, announced unaudited second quarter 2018 revenue and selected business highlights for the quarter ended June 30, 2018.

 

Revenue and Business Highlights for Second Quarter 2018

  • Second quarter 2018 revenue is expected to be $12.3 million, up 203% compared to the second quarter of 2017,

 and a 53% sequential increase over Q1 2018.

 

  • Company increased retail store count to 1,968 natural and organic health food stores as of June 30, 2018, representing an 11.1% sequential increase over the Company’s retail store count for the first quarter of 2018.

 

 Synchronoss (PINK: SNCR) is down, over 25%, at publication time, on heavy volume, after being downgraded to “Sell” from “Hold” by Stifel Nicoulaus. 

 

The stock has traded more than $5 million in dollar volume so far today on the US Venture Exchange

 

Connect with 24/7 Market News on social media

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

24/7MN has covered Kraig Biocraft Laboratories, Inc. in the past and owns shares that it may sell at any time. You may view this as a conflict of interest. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com 

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.com

 

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/